USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

report img

Nasal Swab Test Market By Product Type (Non-woven, Foam-tipped Swabs, and Others), By Diagnostics Type (Molecular Diagnostics, CRISPR & Biosensors, and Others), By Mode (Point-of-Care, and Non-Point-of-Care), and By End-User (Laboratories & Diagnostics Centers, Hospitals & Clinics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026

Covid-19

Nasal Swab Test Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Insights

According to the report published by the Facts and Factors, global demand for the nasal swab test market was estimated at approximately USD 108.7 Million in 2020 and is expected to generate revenue of around USD 150.7 Million by the end of 2026, growing at a CAGR of around 3.4% between 2021 and 2026.

logoMarket Overview

The Coronavirus Disease or COVID-19 is caused by the novel coronavirus SARS-CoV-2 that is an RNA virus. Coronavirus disease can be transmitted from one person to another by means of the inhalation of infectious droplets. Some symptoms of COVID-19 comprise fatigue, dry cough, fever, and body ache. Individuals with conditions like cancer, diabetes, hypertension, old age, and others are at a high risk of getting severe COVID-19 infection. Therefore, it is necessary to expand well-organized nasal swab tests for COVID-19 diagnosis. The nasal swab tests engage the secretion collection from the inner surface of the nostril. Such samples are employed by diagnostic systems like molecular diagnostics, biosensors, immunoassays, and others. COVID-19 nasal swab tests are broadly used by clinics, hospitals, diagnostic centers, laboratories, and others.

logoIndustry Growth Factor

The increase in the number of novel coronavirus cases is the major factor that is driving the expansion of the global nasal swab test market. Furthermore, the growing number of research and development goings-on for the improvement of the efficiency of nasal swab tests is projected to help out the global nasal swab test market during the forecast period. In accordance with the National Institutes of Health (NIH), the United States in July 2020, Helix OpCo LLC, which is a California, based population genomics company, developed standardized nasal swab kits in larger amounts for the collection of nasal secretion samples for the detection of SARS-CoV-2. This allows the processing of thousands of nasal swab samples at once and gives results in 24-48 hours. Such nasal swab kits might be shipped to healthcare systems, employers, public health departments, and others. Moreover, the increasing government funding supporting the research and development activities, which is also expected to propel the global nasal swab tests market growth during the forecast period. 

On the other hand, the increase in product recalls might hamper the growth of the global nasal swab test market in the coming years. Conversely, rapid research is being performed to make low price and accurate nasal swab COVID-19 tests, which is likely to present lucrative opportunities for the market.

Nasal Swab Test Market

logoSegmentation Analysis

The global nasal swab test market has been segmented into product type, diagnostics type, mode, and end-user. On the basis of the type of product, the global nasal swab test market has been classified into non-woven, foam-tipped swabs, and others. Based on the type of diagnostics, the global nasal swab test market has been segmented into Molecular Diagnostics, CRISPR & Biosensors, and others. The global nasal swab test market on the basis of mode has been bifurcated into point-of-care, and non-point-of-care. In terms of the end-user industry, the global nasal swab test market has been divided into laboratories & diagnostics centers, hospitals & clinics, and others.

logo Report Scope

Report Attribute

Details

Market Size in 2020

USD 108.7 Million

Projected Market Size in 2026

USD 150.7 Million

CAGR Growth Rate

3.4% CAGR

Base Year

2020

Forecast Years

2021-2026

Key Market Players

OraSure Technologies Inc, Abbott Laboratories, PrivaPath Diagnostics Limited, Roche Holding AG, QIAGEN N.V., Sherlock Biosciences, Becton Dickinson & Company, GenMark Diagnostics Inc., 3M Corporation, Quidel Corporation, BioMerieux SA, Fluidigm Corporation, Lucira Health, LumiraDx Ltd., Mesa Biotech Inc., Cepheid, and Siemens Healthineers AG, among others.

Key Segment

By Product Type, By Diagnostics Type, By Mode, By End-User, and By Region

Major Regions Covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Purchase Options

Request customized purchase options to meet your research needs. Explore purchase options

logo Regional Analysis

Geographically, the nasal swab test market has been segmented into North America, Asia-Pacific, Latin America, Europe, and the Middle East, and Africa. In terms of region, North America is anticipated to dominate the global nasal swab test market during the estimated period. The increase in the number of product launches, the growing need for diagnostic procedures, and the increasing incidence of infectious diseases are key factors that are likely to contribute significantly to the regional market upsurge. Moreover, the occurrence of top-notch research centers in addition to the rising demand for medical swabs will further assist the regional market to grow in the coming years.

The region of Asia-Pacific is projected to witness profitable growth opportunities in the forthcoming years. This can be attributed to the increase in cases of coronavirus because of the presence of high populated countries such as India, China, Japan, and others. Besides, the escalating number of coronavirus testing facilities in developing economies is expected to help the Asia-Pacific market during the forecast period.

logo Competitive Players

Various key players covered in the global nasal swab test market include OraSure Technologies Inc, Abbott Laboratories, PrivaPath Diagnostics Limited, Roche Holding AG, QIAGEN N.V., Sherlock Biosciences, Becton Dickinson & Company, GenMark Diagnostics Inc., 3M Corporation, Quidel Corporation, BioMerieux SA, Fluidigm Corporation, Lucira Health, LumiraDx Ltd., Mesa Biotech Inc., Cepheid, and Siemens Healthineers AG, among others. Moreover, the foremost companies are focusing more on marketing strategies such as collaborations, partnerships, and others, this, in turn, is anticipated to propel the growth of the global nasal swab test market.

logo Product Type Segment Analysis

  • Non-woven
  • Foam-tipped Swabs
  • Others

logo Diagnostics Type Segment Analysis

  • Molecular Diagnostics
  • CRISPR & Biosensors
  • Others 

logo Mode Segment Analysis

  • Point-of-Care
  • Non-Point-of-Care

logo End-User Segment Analysis

  • Laboratories & Diagnostics Centers
  • Hospitals & Clinics
  • Others

logo Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • France
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • The Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East Africa

Covid-19

Nasal Swab Test Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Table of Content

  1. Chapter 1 Executive Summary
    1. 1.1. Introduction of Nasal Swab Test
    2. 1.2. Global Nasal Swab Test Market, 2019 & 2026 (USD Million)
    3. 1.3. Global Nasal Swab Test Market, 2016 – 2026(USD Million)
    4. 1.4. Global Nasal Swab Test MarketAbsolute Revenue Opportunity, 2016 – 2026(USD Million)
    5. 1.5. Global Nasal Swab Test MarketIncremental Revenue Opportunity, 2020 – 2026(USD Million)
  2. Chapter 2 Nasal Swab Test Market – Product Type Analysis
    1. 2.1. Global Nasal Swab Test Market – Product Type Overview
    2. 2.2. Global Nasal Swab Test Market Share, by Product Type, 2019 & 2026(USD Million)
    3. 2.3. Non-woven
      1. 2.3.1. Global Non-woven Nasal Swab Test Market, 2016 – 2026(USD Million)
    4. 2.4. Foam-tipped Swabs
      1. 2.4.1. Global Foam-tipped Swabs Nasal Swab Test Market, 2016 – 2026(USD Million)
    5. 2.5. Others
      1. 2.5.1. Global Others Nasal Swab Test Market, 2016 – 2026(USD Million)
  3. Chapter 3 Nasal Swab Test Market – Diagnostics Type Analysis
    1. 3.1. Global Nasal Swab Test Market – Diagnostics Type Overview
    2. 3.2. Global Nasal Swab Test Market Share, by Diagnostics Type, 2019 & 2026(USD Million)
    3. 3.3. Molecular Diagnostics
      1. 3.3.1. Global Molecular Diagnostics Nasal Swab Test Market, 2016 – 2026(USD Million)
    4. 3.4. CRISPR & Biosensors
      1. 3.4.1. Global CRISPR & Biosensors Nasal Swab Test Market, 2016 – 2026(USD Million)
    5. 3.5. Others
      1. 3.5.1. Global Others Nasal Swab Test Market, 2016 – 2026(USD Million)
  4. Chapter 4 Nasal Swab Test Market – Mode Analysis
    1. 4.1. Global Nasal Swab Test Market – Mode Overview
    2. 4.2. Global Nasal Swab Test Market Share, by Mode, 2019 & 2026(USD Million)
    3. 4.3. Point-of-Care
      1. 4.3.1. Global Point-of-Care Nasal Swab Test Market, 2016 – 2026(USD Million)
    4. 4.4. Non-Point-of-Care
      1. 4.4.1. Global Non-Point-of-Care Nasal Swab Test Market, 2016 – 2026(USD Million)
  5. Chapter 5 Nasal Swab Test Market – End-User Analysis
    1. 5.1. Global Nasal Swab Test Market – End-User Overview
    2. 5.2. Global Nasal Swab Test Market Share, by End-User, 2019 & 2026(USD Million)
    3. 5.3. Laboratories & Diagnostics Centers
      1. 5.3.1. Global Laboratories & Diagnostics Centers Nasal Swab Test Market, 2016 – 2026(USD Million)
    4. 5.4. Hospitals & Clinics
      1. 5.4.1. Global Hospitals & Clinics Nasal Swab Test Market, 2016 – 2026(USD Million)
    5. 5.5. Others
      1. 5.5.1. Global Others Nasal Swab Test Market, 2016 – 2026(USD Million)
  6. Chapter 6 Nasal Swab Test Market – Regional Analysis
    1. 6.1. Global Nasal Swab Test Market Regional Overview
    2. 6.2. Global Nasal Swab Test Market Share, by Region, 2019 & 2026(USD Million)
    3. 6.3. North America
      1. 6.3.1. North America Nasal Swab Test Market, 2016 – 2026(USD Million)
        1. 6.3.1.1. North America Nasal Swab Test Market, by Country, 2016 - 2026(USD Million)
      2. 6.3.2. North America Nasal Swab Test Market, by Product Type, 2016 – 2026
        1. 6.3.2.1. North America Nasal Swab Test Market, by Product Type, 2016 – 2026(USD Million)
      3. 6.3.3. North America Nasal Swab Test Market, by Diagnostics Type, 2016 – 2026
        1. 6.3.3.1. North America Nasal Swab Test Market, by Diagnostics Type, 2016 – 2026(USD Million)
      4. 6.3.4. North America Nasal Swab Test Market, by Mode, 2016 – 2026
        1. 6.3.4.1. North America Nasal Swab Test Market, by Mode, 2016 – 2026(USD Million)
      5. 6.3.5. North America Nasal Swab Test Market, by End-User, 2016 – 2026
        1. 6.3.5.1. North America Nasal Swab Test Market, by End-User, 2016 – 2026(USD Million)
      6. 6.3.6. U.S.
        1. 6.3.6.1. U.S. Nasal Swab Test Market, 2016 – 2026(USD Million)
      7. 6.3.7. Canada
        1. 6.3.7.1. Canada Nasal Swab Test Market, 2016 – 2026(USD Million)
    4. 6.4. Europe
      1. 6.4.1. Europe Nasal Swab Test Market, 2016 – 2026(USD Million)
        1. 6.4.1.1. Europe Nasal Swab Test Market, by Country, 2016 - 2026(USD Million)
      2. 6.4.2. Europe Nasal Swab Test Market, by Product Type, 2016 – 2026
        1. 6.4.2.1. Europe Nasal Swab Test Market, by Product Type, 2016 – 2026(USD Million)
      3. 6.4.3. Europe Nasal Swab Test Market, by Diagnostics Type, 2016 – 2026
        1. 6.4.3.1. Europe Nasal Swab Test Market, by Diagnostics Type, 2016 – 2026(USD Million)
      4. 6.4.4. Europe Nasal Swab Test Market, by Mode, 2016 – 2026
        1. 6.4.4.1. Europe Nasal Swab Test Market, by Mode, 2016 – 2026(USD Million)
      5. 6.4.5. Europe Nasal Swab Test Market, by End-User, 2016 – 2026
        1. 6.4.5.1. Europe Nasal Swab Test Market, by End-User, 2016 – 2026(USD Million)
      6. 6.4.6. Germany
        1. 6.4.6.1. Germany Nasal Swab Test Market, 2016 – 2026(USD Million)
      7. 6.4.7. France
        1. 6.4.7.1. France Nasal Swab Test Market, 2016 – 2026(USD Million)
      8. 6.4.8. U.K.
        1. 6.4.8.1. U.K. Nasal Swab Test Market, 2016 – 2026(USD Million)
      9. 6.4.9. Italy
        1. 6.4.9.1. Italy Nasal Swab Test Market, 2016 – 2026(USD Million)
      10. 6.4.10. Spain
        1. 6.4.10.1. Spain Nasal Swab Test Market, 2016 – 2026(USD Million)
      11. 6.4.11. Rest of Europe
        1. 6.4.11.1. Rest of Europe Nasal Swab Test Market, 2016 – 2026(USD Million)
    5. 6.5. Asia Pacific
      1. 6.5.1. Asia Pacific Nasal Swab Test Market, 2016 – 2026(USD Million)
        1. 6.5.1.1. Asia Pacific Nasal Swab Test Market, by Country, 2016 - 2026(USD Million)
      2. 6.5.2. Asia Pacific Nasal Swab Test Market, by Product Type, 2016 – 2026
        1. 6.5.2.1. Asia Pacific Nasal Swab Test Market, by Product Type, 2016 – 2026(USD Million)
      3. 6.5.3. Asia Pacific Nasal Swab Test Market, by Diagnostics Type, 2016 – 2026
        1. 6.5.3.1. Asia Pacific Nasal Swab Test Market, by Diagnostics Type, 2016 – 2026(USD Million)
      4. 6.5.4. Asia Pacific Nasal Swab Test Market, by Mode, 2016 – 2026
        1. 6.5.4.1. Asia Pacific Nasal Swab Test Market, by Mode, 2016 – 2026(USD Million)
      5. 6.5.5. Asia Pacific Nasal Swab Test Market, by End-User, 2016 – 2026
        1. 6.5.5.1. Asia Pacific Nasal Swab Test Market, by End-User, 2016 – 2026(USD Million)
      6. 6.5.6. China
        1. 6.5.6.1. China Nasal Swab Test Market, 2016 – 2026(USD Million)
      7. 6.5.7. Japan
        1. 6.5.7.1. Japan Nasal Swab Test Market, 2016 – 2026(USD Million)
      8. 6.5.8. India
        1. 6.5.8.1. India Nasal Swab Test Market, 2016 – 2026(USD Million)
      9. 6.5.9. South Korea
        1. 6.5.9.1. South Korea Nasal Swab Test Market, 2016 – 2026(USD Million)
      10. 6.5.10. South-East Asia
        1. 6.5.10.1. South-East Asia Nasal Swab Test Market, 2016 – 2026(USD Million)
      11. 6.5.11. Rest of Asia Pacific
        1. 6.5.11.1. Rest of Asia Pacific Nasal Swab Test Market, 2016 – 2026(USD Million)
    6. 6.6. Latin America
      1. 6.6.1. Latin America Nasal Swab Test Market, 2016 – 2026(USD Million)
        1. 6.6.1.1. Latin America Nasal Swab Test Market, by Country, 2016 - 2026(USD Million)
      2. 6.6.2. Latin America Nasal Swab Test Market, by Product Type, 2016 – 2026
        1. 6.6.2.1. Latin America Nasal Swab Test Market, by Product Type, 2016 – 2026(USD Million)
      3. 6.6.3. Latin America Nasal Swab Test Market, by Diagnostics Type, 2016 – 2026
        1. 6.6.3.1. Latin America Nasal Swab Test Market, by Diagnostics Type, 2016 – 2026(USD Million)
      4. 6.6.4. Latin America Nasal Swab Test Market, by Mode, 2016 – 2026
        1. 6.6.4.1. Latin America Nasal Swab Test Market, by Mode, 2016 – 2026(USD Million)
      5. 6.6.5. Latin America Nasal Swab Test Market, by End-User, 2016 – 2026
        1. 6.6.5.1. Latin America Nasal Swab Test Market, by End-User, 2016 – 2026(USD Million)
      6. 6.6.6. Brazil
        1. 6.6.6.1. Brazil Nasal Swab Test Market, 2016 – 2026(USD Million)
      7. 6.6.7. Mexico
        1. 6.6.7.1. Mexico Nasal Swab Test Market, 2016 – 2026(USD Million)
      8. 6.6.8. Rest of Latin America
        1. 6.6.8.1. Rest of Latin America Nasal Swab Test Market, 2016 – 2026(USD Million)
    7. 6.7. The Middle-East and Africa
      1. 6.7.1. The Middle-East and Africa Nasal Swab Test Market, 2016 – 2026(USD Million)
        1. 6.7.1.1. The Middle-East and Africa Nasal Swab Test Market, by Country, 2016 - 2026(USD Million)
      2. 6.7.2. The Middle-East and Africa Nasal Swab Test Market, by Product Type, 2016 – 2026
        1. 6.7.2.1. The Middle-East and Africa Nasal Swab Test Market, by Product Type, 2016 – 2026(USD Million)
      3. 6.7.3. The Middle-East and Africa Nasal Swab Test Market, by Diagnostics Type, 2016 – 2026
        1. 6.7.3.1. The Middle-East and Africa Nasal Swab Test Market, by Diagnostics Type, 2016 – 2026(USD Million)
      4. 6.7.4. The Middle-East and Africa Nasal Swab Test Market, by Mode, 2016 – 2026
        1. 6.7.4.1. The Middle-East and Africa Nasal Swab Test Market, by Mode, 2016 – 2026(USD Million)
      5. 6.7.5. The Middle-East and Africa Nasal Swab Test Market, by End-User, 2016 – 2026
        1. 6.7.5.1. The Middle-East and Africa Nasal Swab Test Market, by End-User, 2016 – 2026(USD Million)
      6. 6.7.6. GCC Countries
        1. 6.7.6.1. GCC Countries Nasal Swab Test Market, 2016 – 2026(USD Million)
      7. 6.7.7. South Africa
        1. 6.7.7.1. South Africa Nasal Swab Test Market, 2016 – 2026(USD Million)
      8. 6.7.8. Rest of Middle-East Africa
        1. 6.7.8.1. Rest of Middle-East Africa Nasal Swab Test Market, 2016 – 2026(USD Million)
  7. Chapter 7 Nasal Swab Test Market – Competitive Landscape
    1. 7.1. Competitor Market Share – Revenue
    2. 7.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 7.3. Strategic Developments
      1. 7.3.1. Acquisitions and Mergers
      2. 7.3.2. New Products
      3. 7.3.3. Research & Development Activities
  8. Chapter 8 Company Profiles
    1. 8.1. OraSure Technologies Inc
      1. 8.1.1. Company Overview
      2. 8.1.2. Product/ServicePortfolio
      3. 8.1.3. OraSure Technologies Inc Sales, Revenue, and Gross Margin
      4. 8.1.4. OraSure Technologies Inc Revenue and Growth Rate
      5. 8.1.5. OraSure Technologies Inc Market Share
      6. 8.1.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    2. 8.2. Abbott Laboratories
      1. 8.2.1. Company Overview
      2. 8.2.2. Product/ServicePortfolio
      3. 8.2.3. Abbott Laboratories Sales, Revenue, and Gross Margin
      4. 8.2.4. Abbott Laboratories Revenue and Growth Rate
      5. 8.2.5. Abbott Laboratories Market Share
      6. 8.2.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    3. 8.3. PrivaPath Diagnostics Limited
      1. 8.3.1. Company Overview
      2. 8.3.2. Product/ServicePortfolio
      3. 8.3.3. PrivaPath Diagnostics Limited Sales, Revenue, and Gross Margin
      4. 8.3.4. PrivaPath Diagnostics Limited Revenue and Growth Rate
      5. 8.3.5. PrivaPath Diagnostics Limited Market Share
      6. 8.3.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    4. 8.4. Roche Holding AG
      1. 8.4.1. Company Overview
      2. 8.4.2. Product/ServicePortfolio
      3. 8.4.3. Roche Holding AG Sales, Revenue, and Gross Margin
      4. 8.4.4. Roche Holding AG Revenue and Growth Rate
      5. 8.4.5. Roche Holding AG Market Share
      6. 8.4.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    5. 8.5. QIAGEN N.V.
      1. 8.5.1. Company Overview
      2. 8.5.2. Product/ServicePortfolio
      3. 8.5.3. QIAGEN N.V. Sales, Revenue, and Gross Margin
      4. 8.5.4. QIAGEN N.V. Revenue and Growth Rate
      5. 8.5.5. QIAGEN N.V. Market Share
      6. 8.5.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    6. 8.6. Sherlock Biosciences
      1. 8.6.1. Company Overview
      2. 8.6.2. Product/ServicePortfolio
      3. 8.6.3. Sherlock Biosciences Sales, Revenue, and Gross Margin
      4. 8.6.4. Sherlock Biosciences Revenue and Growth Rate
      5. 8.6.5. Sherlock Biosciences Market Share
      6. 8.6.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    7. 8.7. Becton Dickinson & Company
      1. 8.7.1. Company Overview
      2. 8.7.2. Product/ServicePortfolio
      3. 8.7.3. Becton Dickinson & Company Sales, Revenue, and Gross Margin
      4. 8.7.4. Becton Dickinson & Company Revenue and Growth Rate
      5. 8.7.5. Becton Dickinson & Company Market Share
      6. 8.7.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    8. 8.8. GenMark Diagnostics Inc.
      1. 8.8.1. Company Overview
      2. 8.8.2. Product/ServicePortfolio
      3. 8.8.3. GenMark Diagnostics Inc. Sales, Revenue, and Gross Margin
      4. 8.8.4. GenMark Diagnostics Inc. Revenue and Growth Rate
      5. 8.8.5. GenMark Diagnostics Inc. Market Share
      6. 8.8.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    9. 8.9. 3M Corporation
      1. 8.9.1. Company Overview
      2. 8.9.2. Product/ServicePortfolio
      3. 8.9.3. 3M Corporation Sales, Revenue, and Gross Margin
      4. 8.9.4. 3M Corporation Revenue and Growth Rate
      5. 8.9.5. 3M Corporation Market Share
      6. 8.9.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    10. 8.10. Quidel Corporation
      1. 8.10.1. Company Overview
      2. 8.10.2. Product/ServicePortfolio
      3. 8.10.3. Quidel Corporation Sales, Revenue, and Gross Margin
      4. 8.10.4. Quidel Corporation Revenue and Growth Rate
      5. 8.10.5. Quidel Corporation Market Share
      6. 8.10.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    11. 8.11. BioMerieux SA
      1. 8.11.1. Company Overview
      2. 8.11.2. Product/ServicePortfolio
      3. 8.11.3. BioMerieux SA Sales, Revenue, and Gross Margin
      4. 8.11.4. BioMerieux SA Revenue and Growth Rate
      5. 8.11.5. BioMerieux SA Market Share
      6. 8.11.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    12. 8.12. Fluidigm Corporation
      1. 8.12.1. Company Overview
      2. 8.12.2. Product/ServicePortfolio
      3. 8.12.3. Fluidigm Corporation Sales, Revenue, and Gross Margin
      4. 8.12.4. Fluidigm Corporation Revenue and Growth Rate
      5. 8.12.5. Fluidigm Corporation Market Share
      6. 8.12.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    13. 8.13. Lucira Health
      1. 8.13.1. Company Overview
      2. 8.13.2. Product/ServicePortfolio
      3. 8.13.3. Lucira Health Sales, Revenue, and Gross Margin
      4. 8.13.4. Lucira Health Revenue and Growth Rate
      5. 8.13.5. Lucira Health Market Share
      6. 8.13.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    14. 8.14. LumiraDx Ltd.
      1. 8.14.1. Company Overview
      2. 8.14.2. Product/ServicePortfolio
      3. 8.14.3. LumiraDx Ltd. Sales, Revenue, and Gross Margin
      4. 8.14.4. LumiraDx Ltd. Revenue and Growth Rate
      5. 8.14.5. LumiraDx Ltd. Market Share
      6. 8.14.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    15. 8.15. Mesa Biotech Inc.
      1. 8.15.1. Company Overview
      2. 8.15.2. Product/ServicePortfolio
      3. 8.15.3. Mesa Biotech Inc. Sales, Revenue, and Gross Margin
      4. 8.15.4. Mesa Biotech Inc. Revenue and Growth Rate
      5. 8.15.5. Mesa Biotech Inc. Market Share
      6. 8.15.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    16. 8.16. Cepheid
      1. 8.16.1. Company Overview
      2. 8.16.2. Product/ServicePortfolio
      3. 8.16.3. Cepheid Sales, Revenue, and Gross Margin
      4. 8.16.4. Cepheid Revenue and Growth Rate
      5. 8.16.5. Cepheid Market Share
      6. 8.16.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    17. 8.17. Siemens Healthineers AG
      1. 8.17.1. Company Overview
      2. 8.17.2. Product/ServicePortfolio
      3. 8.17.3. Siemens Healthineers AG Sales, Revenue, and Gross Margin
      4. 8.17.4. Siemens Healthineers AG Revenue and Growth Rate
      5. 8.17.5. Siemens Healthineers AG Market Share
      6. 8.17.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
  9. Chapter 9 Nasal Swab Test — Industry Analysis
    1. 9.1. Introduction and Taxonomy
    2. 9.2. Nasal Swab Test Market – Key Trends
      1. 9.2.1. Market Drivers
      2. 9.2.2. Market Restraints
      3. 9.2.3. Market Opportunities
    3. 9.3. Value Chain Analysis
    4. 9.4. Key Mandates and Regulations
    5. 9.5. Technology Roadmap and Timeline
    6. 9.6. Nasal Swab Test Market – Attractiveness Analysis
      1. 9.6.1. By Product Type
      2. 9.6.2. By Diagnostics Type
      3. 9.6.3. By Mode
      4. 9.6.4. By End-User
      5. 9.6.5. By Region
  10. Chapter 10 Industrial Chain, Sourcing Strategy, and Downstream Buyers
    1. 10.1. Nasal Swab Test Industrial Chain Analysis
    2. 10.2. Downstream Buyers
    3. 10.3. Distributors/Traders List
  11. Chapter 11 Marketing Strategy Analysis
    1. 11.1. Marketing Channel
    2. 11.2. Direct Marketing
    3. 11.3. Indirect Marketing
    4. 11.4. Marketing Channel Development Trends
    5. 11.5. Economic/Political Environmental Change
  12. Chapter 12 Report Conclusion& Key Insights
    1. 12.1. Key Insights from Primary Interviews & Surveys Respondents
    2. 12.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  13. Chapter 13 Research Approach & Methodology
    1. 13.1. Report Description
    2. 13.2. Research Scope
    3. 13.3. Research Methodology
      1. 13.3.1. Secondary Research
      2. 13.3.2. Primary Research
      3. 13.3.3. Statistical Models
        1. 13.3.3.1. Company Share Analysis Model
        2. 13.3.3.2. Revenue Based Modeling
      4. 13.3.4. Research Limitations

      List of Figures

      Fig.1	Product Picture of  Nasal Swab Test
      Fig.2	Global  Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.3	Global  Nasal Swab Test  MarketAbsolute Revenue Opportunity, 2016 – 2026(USD Million)
      Fig.4	Global  Nasal Swab Test  MarketIncremental Revenue Opportunity, 2020 – 2026(USD Million)
      Fig.5	Global  Nasal Swab Test  Market Share, by Product Type, 2019 & 2026(USD Million)
      Fig.6	Global Non-woven Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.7	Global Foam-tipped Swabs Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.8	Global Others Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.9	Global  Nasal Swab Test  Market Share, by Diagnostics Type, 2019 & 2026(USD Million)
      Fig.10	Global Molecular Diagnostics Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.11	Global CRISPR & Biosensors Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.12	Global Others Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.13	Global  Nasal Swab Test  Market Share, by Mode, 2019 & 2026(USD Million)
      Fig.14	Global Point-of-Care Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.15	Global Non-Point-of-Care Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.16	Global  Nasal Swab Test  Market Share, by End-User, 2019 & 2026(USD Million)
      Fig.17	Global Laboratories & Diagnostics Centers Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.18	Global Hospitals & Clinics Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.19	Global Others Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.20	Global  Nasal Swab Test  MarketShare, by Region, 2019 & 2026(USD Million)
      Fig.21	North America Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.22	U.S. Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.23	Canada Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.24	Europe Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.25	Germany Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.26	France Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.27	U.K. Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.28	Italy Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.29	Spain Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.30	Rest of Europe Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.31	Asia Pacific Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.32	China Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.33	Japan Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.34	India Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.35	South  Korea Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.36	South-East Asia Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.37	Rest of Asia Pacific Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.38	Latin America Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.39	Brazil Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.40	Mexico Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.41	Rest of Latin America Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.42	The Middle-East and Africa Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.43	GCC Countries Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.44	South Africa Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.45	Rest of Middle-East Africa Nasal Swab Test  Market, 2016 – 2026(USD Million)
      Fig.46	Competitor Market Share – Revenue
      Fig.47	OraSure Technologies Inc Revenue and Growth Rate
      Fig.48	OraSure Technologies Inc Market Share
      Fig.49	Abbott Laboratories Revenue and Growth Rate
      Fig.50	Abbott Laboratories Market Share
      Fig.51	PrivaPath Diagnostics Limited Revenue and Growth Rate
      Fig.52	PrivaPath Diagnostics Limited Market Share
      Fig.53	Roche Holding AG Revenue and Growth Rate
      Fig.54	Roche Holding AG Market Share
      Fig.55	QIAGEN N.V. Revenue and Growth Rate
      Fig.56	QIAGEN N.V. Market Share
      Fig.57	Sherlock Biosciences Revenue and Growth Rate
      Fig.58	Sherlock Biosciences Market Share
      Fig.59	Becton Dickinson & Company Revenue and Growth Rate
      Fig.60	Becton Dickinson & Company Market Share
      Fig.61	GenMark Diagnostics Inc. Revenue and Growth Rate
      Fig.62	GenMark Diagnostics Inc. Market Share
      Fig.63	3M Corporation Revenue and Growth Rate
      Fig.64	3M Corporation Market Share
      Fig.65	Quidel Corporation Revenue and Growth Rate
      Fig.66	Quidel Corporation Market Share
      Fig.67	BioMerieux SA Revenue and Growth Rate
      Fig.68	BioMerieux SA Market Share
      Fig.69	Fluidigm Corporation Revenue and Growth Rate
      Fig.70	Fluidigm Corporation Market Share
      Fig.71	Lucira Health Revenue and Growth Rate
      Fig.72	Lucira Health Market Share
      Fig.73	LumiraDx Ltd. Revenue and Growth Rate
      Fig.74	LumiraDx Ltd. Market Share
      Fig.75	Mesa Biotech Inc. Revenue and Growth Rate
      Fig.76	Mesa Biotech Inc. Market Share
      Fig.77	Cepheid Revenue and Growth Rate
      Fig.78	Cepheid Market Share
      Fig.79	Siemens Healthineers AG Revenue and Growth Rate
      Fig.80	Siemens Healthineers AG Market Share
      Fig.81	Market Dynamics
      Fig.82	Global  Nasal Swab Test  – Value Chain Analysis
      Fig.83	Key Mandates and Regulations
      Fig.84	Technology Roadmap and Timeline
      Fig.85	Market Attractiveness Analysis – By Product Type
      Fig.86	Market Attractiveness Analysis – By Diagnostics Type
      Fig.87	Market Attractiveness Analysis – By Mode
      Fig.88	Market Attractiveness Analysis – By End-User
      Fig.89	Market Attractiveness Analysis – By Region
      Fig.90	Nasal Swab Test  Industrial Chain Analysis
      Fig.91	Market Channels
      Fig.92	Marketing Channel Development Trend
      Fig.93	Growth in World Gross Product, 2008-2018
      

      List of Tables

      Table 1	Global  Nasal Swab Test Market, 2019 & 2026(USD Million)
      Table 2	Global  Nasal Swab Test Market, by Product Type, 2016 – 2026(USD Million)
      Table 3	Global  Nasal Swab Test Market, by Diagnostics Type, 2016 – 2026(USD Million)
      Table 4	Global  Nasal Swab Test Market, by Mode, 2016 – 2026(USD Million)
      Table 5	Global  Nasal Swab Test Market, by End-User, 2016 – 2026(USD Million)
      Table 6	Global  Nasal Swab Test Market, by Region, 2016 – 2026(USD Million)
      Table 7	North America Nasal Swab Test  Market, by Country, 2016 – 2026(USD Million)
      Table 8	North America Nasal Swab Test  Market, by Product Type, 2016 – 2026(USD Million)
      Table 9	North America Nasal Swab Test  Market, by Diagnostics Type, 2016 – 2026(USD Million)
      Table 10North America Nasal Swab Test  Market, by Mode, 2016 – 2026(USD Million)
      Table 11North America Nasal Swab Test  Market, by End-User, 2016 – 2026(USD Million)
      Table 12Europe Nasal Swab Test  Market, by Country, 2016 – 2026(USD Million)
      Table 13Europe Nasal Swab Test  Market, by Product Type, 2016 – 2026(USD Million)
      Table 14Europe Nasal Swab Test  Market, by Diagnostics Type, 2016 – 2026(USD Million)
      Table 15Europe Nasal Swab Test  Market, by Mode, 2016 – 2026(USD Million)
      Table 16Europe Nasal Swab Test  Market, by End-User, 2016 – 2026(USD Million)
      Table 17Asia Pacific Nasal Swab Test  Market, by Country, 2016 – 2026(USD Million)
      Table 18Asia Pacific Nasal Swab Test  Market, by Product Type, 2016 – 2026(USD Million)
      Table 19Asia Pacific Nasal Swab Test  Market, by Diagnostics Type, 2016 – 2026(USD Million)
      Table 20Asia Pacific Nasal Swab Test  Market, by Mode, 2016 – 2026(USD Million)
      Table 21Asia Pacific Nasal Swab Test  Market, by End-User, 2016 – 2026(USD Million)
      Table 22Latin America Nasal Swab Test  Market, by Country, 2016 – 2026(USD Million)
      Table 23Latin America Nasal Swab Test  Market, by Product Type, 2016 – 2026(USD Million)
      Table 24Latin America Nasal Swab Test  Market, by Diagnostics Type, 2016 – 2026(USD Million)
      Table 25Latin America Nasal Swab Test  Market, by Mode, 2016 – 2026(USD Million)
      Table 26Latin America Nasal Swab Test  Market, by End-User, 2016 – 2026(USD Million)
      Table 27The Middle-East and Africa Nasal Swab Test  Market, by Country, 2016 – 2026(USD Million)
      Table 28The Middle-East and Africa Nasal Swab Test  Market, by Product Type, 2016 – 2026(USD Million)
      Table 29The Middle-East and Africa Nasal Swab Test  Market, by Diagnostics Type, 2016 – 2026(USD Million)
      Table 30The Middle-East and Africa Nasal Swab Test  Market, by Mode, 2016 – 2026(USD Million)
      Table 31The Middle-East and Africa Nasal Swab Test  Market, by End-User, 2016 – 2026(USD Million)
      Table 32Global  Nasal Swab Test  Market - Company Revenue Analysis, 2016 – 2019(USD Million)
      Table 33Global  Nasal Swab Test  Market - Company Revenue Share Analysis, 2016 – 2019(%)
      Table 34Acquisitions and Mergers
      Table 35Market Drivers – Impact Analysis
      Table 36Market Restraints
      Table 37Market Opportunities
      Table 38Major Buyers of  Nasal Swab Test
      Table 39Distributors/Traders of  Nasal Swab Test  by Region
      

Covid-19

Nasal Swab Test Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Major Market Players

  • OraSure Technologies Inc
  • Abbott Laboratories
  • PrivaPath Diagnostics Limited
  • Roche Holding AG
  • QIAGEN N.V.
  • Sherlock Biosciences
  • Becton Dickinson & Company
  • GenMark Diagnostics Inc.
  • 3M Corporation
  • Quidel Corporation
  • BioMerieux SA
  • Fluidigm Corporation
  • Lucira Health
  • LumiraDx Ltd.
  • Mesa Biotech Inc.
  • Cepheid
  • Siemens Healthineers AG

Frequently Asked Questions

The increase in the number of novel coronavirus cases is the major factor that is driving the expansion of the global nasal swab test market.
The global demand for the nasal swab test market was estimated at approximately USD 108.7 Million in 2020 and is expected to generate revenue of around USD 150.7 Million by the end of 2026, growing at a CAGR of around 3.4% between 2021 and 2026.
In terms of region, North America is anticipated to dominate the global nasal swab test market during the estimated period.
Various key players covered in the global nasal swab test market include OraSure Technologies Inc, Abbott Laboratories, PrivaPath Diagnostics Limited, Roche Holding AG, QIAGEN N.V., Sherlock Biosciences, Becton Dickinson & Company, GenMark Diagnostics Inc., 3M Corporation, Quidel Corporation, BioMerieux SA, Fluidigm Corporation, Lucira Health, LumiraDx Ltd., Mesa Biotech Inc., Cepheid, and Siemens Healthineers AG, among others.
why choose fnf
key questions answers

Related Reports

report img

Anesthesia Gas Mixers Market Report 2021 – 2026

Facts Factors recently published a report on theglobal anesthesia gas mixers market. The report encompasses market statistics and analytics. The market value of the anesthesia gas mixers market was witnessed to be USD 500 Million in 2020 and with growth at a CAGR of 6% is projected to reach a val...

Published Date : 28-Dec-2021 | | Category : | Pages : 171 | Format : Read more

Inquiry for Buying Request Sample
report img

Anesthesia Equipment Market Report 2021 – 2026

According to Facts Factors, the report on the Global Anesthesia Equipment Market encompasses the complete history and forecast details. In this report, the market value was witnessed to be around USD 11 Billion in 2020 and with a CAGR of 6.5% will acquire USD 16 Billion by 2026. Report Overview...

Published Date : 28-Dec-2021 | | Category : | Pages : 171 | Format : Read more

Inquiry for Buying Request Sample